V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290006478 | 290007940 | 1.67 | 68 | Curative (C) | null | 2016-12-22 | Capecitabine + Oxaliplatin 21day | null | null | 290018989 | CISPLATIN + ETOPOSIDE |
| 290006479 | 290004838 | 1.7 | 56 | Curative (C) | 2014-05-08 | 2014-05-12 | Cetuximab 7 day (>Cycle 2) | 02 | N | 290018997 | FLUOROURACIL + MITOMYCIN |
| 290006480 | 290004839 | 1.73 | 74.8 | Adjuvant (A) | 2014-02-01 | 2014-03-26 | Cisplatin + Docetaxel +Fluorouracil | N | null | 290019008 | CAPECITABINE + OXALIPLATIN |
| 290006481 | 290004841 | 0 | 81 | Palliative (P) | 2014-05-02 | 2014-05-02 | Cetuximab + FOLFIRI cycle 2 onwards | 01 | N | 290019010 | SUNITINIB |
| 290006482 | 290004841 | 1.59 | null | Palliative (P) | 2018-01-10 | 2018-01-10 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | 290019010 | CARBOPLATIN |
| 290006483 | 290004844 | 1.66 | 69 | Curative (C) | 2015-04-25 | 2015-05-03 | CARBOPLATIN + PACLITAXEL | 02 | Y | 290019012 | FLUOROURACIL + MITOMYCIN |
| 290006484 | 290004845 | 1.78 | 83.6 | Curative (C) | 2016-04-30 | 2016-05-21 | Capecitabine | 2 | N | 290019036 | BALLAD TRIAL |
| 290006485 | 290004845 | 1.57 | 62.75 | Palliative (P) | null | 2016-11-11 | Docetaxel 75mg/m2 (21 day) | 02 | Y | 290019036 | CAPECITABINE + IRINOTECAN |
| 290006486 | 290004845 | 1.66 | 69 | null | 2016-02-13 | 2016-02-14 | Paclitaxel 80mg/m2 day 1 8 15 | N | null | 290019036 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290006487 | 290004848 | null | null | Palliative (P) | 2018-05-19 | 2018-07-06 | CETUXIMAB | N | null | 290019042 | EVEROLIMUS |
| 290006488 | 290004849 | 1.6 | 78 | Curative (C) | 2018-06-14 | 2018-06-28 | LANREOTIDE | 02 | N | 290019046 | CISPLATIN + RT |
| 290006489 | 290004849 | 1.76 | 94.5 | Curative (C) | 2016-05-15 | 2016-11-01 | Carboplatin + Etoposide IV 3 day | N | N | 290019046 | ESHAP |
| 290006490 | 290004849 | 1.79 | 62.5 | Not known (9) | 2015-07-13 | 2015-07-21 | Capecitabine (21 day) + Irinotecan | 02 | N | 290019046 | CETUXIMAB |
| 290006491 | 290004849 | 1.64 | null | Curative (C) | 2015-11-04 | 2015-12-01 | Cisplatin 100 + RT(H&N) 1 day | null | null | 290019046 | CARBOPLATIN + RT |
| 290006492 | 290004849 | 1.76 | 80.4 | Palliative (P) | 2016-03-26 | 2016-03-31 | Oxaliplatin + Raltitrexed | N | null | 290019046 | OCTREOTIDE |
| 290006493 | 290004852 | null | 97.4 | Curative (C) | 2014-09-02 | 2014-11-17 | LANREOTIDE | 02 | Y | 290019084 | CARBOPLATIN |
| 290006494 | 290004855 | 0 | 60.9 | Palliative (P) | 2015-10-19 | 2015-10-23 | CETUXIMAB | 2 | N | 290019084 | TRIAL |
| 290006495 | 290004856 | 1.6 | 56.7 | Palliative (P) | 2015-08-18 | 2015-08-18 | Capecitabine + Oxaliplatin 21day | 02 | N | 290019097 | CISPLATIN + FLUOROURACIL + RT |
| 290006496 | 290004857 | 0 | 48.5 | Palliative (P) | 2016-12-18 | 2017-01-03 | CISPLATIN + TEYSUNO | 02 | N | 290019099 | PACLITAXEL |
| 290006497 | 290004858 | 1.73 | null | Adjuvant (A) | 2012-08-11 | 2013-10-25 | PACLITAXEL | N | N | 290019104 | CISPLATIN |
| 290006498 | 290004859 | 1.49 | 60.8 | Adjuvant (A) | 2014-03-12 | 2014-04-10 | Capecitabine + Cisplatin | N | N | 290019112 | CAPECITABINE + OXALIPLATIN |
| 290006499 | 290004861 | 1.53 | 53.9 | Curative (C) | null | 2013-11-16 | Cisplatin 100 + RT(H&N) 1 day | N | N | 290019134 | TRIAL |
| 290006500 | 290004862 | 1.6 | 73 | Curative (C) | 2013-09-10 | 2014-03-14 | Sunitinib | 02 | N | 290019141 | CETUXIMAB |
| 290006501 | 290004863 | 1.73 | 0 | null | 2016-12-31 | 2017-01-19 | Hydroxycarbamide | 02 | N | 290019146 | FLUOROURACIL + MITOMYCIN |
| 290006502 | 290004864 | null | null | Adjuvant (A) | 2016-03-30 | 2016-04-28 | CYTARABINE + DAUNORUBICIN | 02 | N | 290019154 | CAPECITABINE |
| 290006503 | 290004865 | 1.62 | 0 | Palliative (P) | 2018-01-07 | 2018-01-20 | PERTUZUMAB + TRASTUZUMAB | 02 | N | 290019170 | PEMBROLIZUMAB |
| 290006504 | 290004866 | 1.77 | 72 | Palliative (P) | 2016-09-04 | 2016-09-18 | Docetaxel | 2 | N | 290019175 | TRIAL |
| 290006505 | 290004869 | 1.63 | 0 | Palliative (P) | 2013-08-24 | 2014-08-13 | AFLIBERCEPT + FU + IRINOTECAN | 02 | Y | 290019178 | CAPECITABINE |
| 290006506 | 290004870 | 1.89 | 75.9 | Palliative (P) | 2014-10-08 | 2014-10-08 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 2 | N | 290019178 | CAPECITABINE + OXALIPLATIN |
| 290006507 | 290004870 | 1.72 | 56.5 | Palliative (P) | 2012-06-08 | 2012-07-19 | ACE (3 day) | n | N | 290019178 | CETUXIMAB |
| 290006508 | 290004871 | 1.83 | 62.9 | Palliative (P) | 2017-07-30 | 2017-08-05 | CISPLATIN + RT | N | null | 290019189 | TRASTUZUMAB + VINORELBINE |
| 290006509 | 290004873 | 1.73 | 75.9 | Palliative (P) | 2012-08-03 | 2012-12-27 | Capecitabine + Oxaliplatin 21day | N | N | 290019197 | CAPECITABINE + OXALIPLATIN |
| 290006510 | 290004873 | 1.8 | 71.8 | Palliative (P) | 2016-01-18 | 2016-02-24 | Capecitabine + Oxaliplatin 21day | 02 | N | 290019197 | CETUXIMAB + IRINOTECAN + MDG |
| 290006511 | 290004873 | 1.64 | 77.2 | Curative (C) | 2015-07-18 | 2015-07-28 | CETUXIMAB | N | null | 290019197 | CARBOPLATIN + RT |
| 290006512 | 290004874 | 1.46 | 60.5 | Adjuvant (A) | 2015-06-27 | 2015-07-22 | CARBOPLATIN + ETOPOSIDE | 02 | N | 290019230 | CAPECITABINE + OXALIPLATIN |
| 290006513 | 290004875 | 1.77 | 53.7 | Adjuvant (A) | 2016-10-08 | 2016-10-10 | LANREOTIDE | 2 | N | 290019233 | ECX |
| 290006514 | 290004878 | 1.77 | 51.3 | Palliative (P) | 2017-11-26 | 2017-12-03 | Capecitabine (14 days)+Carboplatin | Y | Y | 290019234 | CAPECITABINE + OXALIPLATIN |
| 290006515 | 290004879 | 1.68 | null | Curative (C) | 2016-06-15 | 2016-06-15 | GEMCARBO | 2 | N | 290019237 | CISPLATIN + RT |
| 290006516 | 290004881 | null | 58 | Palliative (P) | 2017-07-21 | 2017-07-27 | Carboplatin AUC 6 - 10 | N | N | 290019247 | CAPECITABINE + IRINOTECAN |
| 290006517 | 290004881 | 1.6 | 75.4 | Curative (C) | 2015-12-14 | 2015-12-21 | DABRAFENIB + TRAMETINIB | 01 | Y | 290019247 | CARBOPLATIN + RT |
| 290006518 | 290004882 | 1.83 | null | Adjuvant (A) | 2014-10-01 | 2014-10-01 | DA | Y | N | 290019258 | TRASTUZUMAB |
| 290006519 | 290004883 | 1.83 | 66.4 | Palliative (P) | 2016-01-13 | 2016-01-23 | CAV | N | N | 290019258 | CETUXIMAB |
| 290006520 | 290004884 | 1.64 | 81.2 | Palliative (P) | 2016-12-19 | 2017-03-21 | Rituximab | 2 | N | 290019277 | DAIICHI TRIAL |
| 290006521 | 290004885 | 1.75 | 45.5 | Palliative (P) | 2015-05-30 | 2015-07-09 | MITOMYCIN | N | N | 290019280 | OCTREOTIDE |
| 290006522 | 290004885 | 1.53 | 49.9 | Adjuvant (A) | 2017-02-19 | 2017-03-09 | Capecitabine | 02 | N | 290019280 | CISPLATIN + RT |
| 290006523 | 290004887 | null | null | Curative (C) | null | 2015-03-10 | Y-90 | null | null | 290019298 | CYTARABINE INTRATHECAL |
| 290006524 | 290004888 | 1.6 | 53.6 | Palliative (P) | 2014-07-22 | 2014-07-22 | Trial Unspecified | 02 | N | 290019304 | CETUXIMAB |
| 290006525 | 290004890 | 1.9 | 95.7 | Adjuvant (A) | 2017-09-06 | 2017-09-07 | MCX | N | N | 290019304 | CISPLATIN |
| 290006526 | 290008271 | 1.71 | 76 | Palliative (P) | 2014-02-22 | 2014-04-30 | Cetuximab 7 day (>Cycle 2) | N | Y | 290019305 | CETUXIMAB |
| 290006527 | 290004891 | 1.62 | 43.9 | Palliative (P) | null | 2014-12-18 | CAPECITABINE + RT | 02 | N | 290019328 | CAPECITABINE + OXALIPLATIN |